Search

everythinglearnresearchcommunity

for

Search:↓

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Selenium from plants is beneficial and safer for health.

Bioengineered microneedles and nanomedicine offer promising, precise treatments for tissue regeneration.

People with androgenetic alopecia (hair loss) may have a higher risk of developing metabolic syndrome.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

A specific genetic change is linked to mental disorders, intellectual disability, and possibly autoimmune disease in a family.

Organoids can revolutionize medicine by modeling diseases and aiding in personalized treatments.

Interval training is better for heart and metabolic health in reproductive-aged females than regular moderate exercise.

Managing diabetes can lead to eating disorders, and eating disorders can make diabetes harder to control.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Multitarget drugs are needed to better treat complex diseases.

Induced pluripotent stem cells are a major breakthrough in regenerative medicine.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Plant-based sensors can help in healthcare but need skilled technicians.

Autoimmune markers may help diagnose and manage PCOS.

FMH foods may help manage post-acute COVID-19 symptoms safely and easily.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

PCOS may be linked to spina bifida in young females.